Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
JW Antoon, MD White, EM Slaughter… - Cancer biology & …, 2011 - Taylor & Francis
Resistance to chemotherapy remains a significant obstacle in the treatment of hormone-
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
[HTML][HTML] Targeting NFκB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
JW Antoon, MD White, EM Slaughter… - Cancer Biology & …, 2011 - ncbi.nlm.nih.gov
Resistance to chemotherapy remains a significant obstacle in the treatment of hormone-
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
[引用][C] Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
JW Antoon, MD White, EM Slaughter, JL Driver… - Cancer Biology & …, 2011 - cir.nii.ac.jp
Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of
sphingosine kinase-2 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細 …
sphingosine kinase-2 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細 …
Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
JW Antoon, MD White, EM Slaughter… - Cancer Biology & …, 2011 - europepmc.org
Resistance to chemotherapy remains a significant obstacle in the treatment of hormone-
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
Targeting NFκB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
JW Antoon, MD White, EM Slaughter… - Cancer Biology and …, 2011 - pure.psu.edu
Resistance to chemotherapy remains a significant obstacle in the treatment of hormone-
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
JW Antoon, MD White, EM Slaughter… - Cancer biology & …, 2011 - pubmed.ncbi.nlm.nih.gov
Resistance to chemotherapy remains a significant obstacle in the treatment of hormone-
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
JW Antoon, MD White, EM Slaughter… - Cancer Biology & …, 2011 - europepmc.org
Resistance to chemotherapy remains a significant obstacle in the treatment of hormone-
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …
independent breast cancer. Recent evidence suggests that altered sphingolipid signaling …